Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ (53)	$ (19)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances	298	435
Policy charges and fee income	(207)	(524)
Net derivative (gains) losses	321	841
Credit and intent to sell losses on available for sale debt securities and loans	19	64
Investment (gains) losses, net	19	14
Realized and unrealized (gains) losses on trading securities	(15)	(12)
Non-cash long-term incentive compensation expense	11	9
Amortization and depreciation	43	136
Equity (income) loss from limited partnerships	(42)	(15)
Remeasurement of liability for future policy benefits	16	13
Change in market risk benefits	11	24
Changes in:
Reinsurance recoverable	292	(370)
Capitalization of deferred policy acquisition costs	(129)	(124)
Funds withheld payable	(18)	0
Future policy benefits	92	(115)
Current and deferred income taxes	(9)	(700)
Other, net	(189)	55
Net cash provided by (used in) operating activities	460	(288)
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale	1,486	1,270
Mortgage loans on real estate	256	81
Trading account securities	23	55
Short-term investments	270	179
Other	9	188
Payment for the purchase/origination of:
Fixed maturities, available-for-sale	(1,187)	(821)
Mortgage loans on real estate	(404)	(580)
Trading account securities	(27)	(59)
Short-term investments	(251)	0
Other	(72)	(232)
Cash settlements related to derivative instruments, net	(1,080)	(103)
Investment in capitalized software, leasehold improvements and EDP equipment	(24)	(5)
Other, net	(37)	44
Net cash provided by (used in) investing activities	(1,038)	17
Policyholders’ account balances:
Deposits	1,214	3,167
Withdrawals	(3,322)	(2,643)
Transfers (to) from Separate Accounts	427	315
Payments of market risk benefits	(7)	(172)
Changes in securities lending payable	31	0
Change in collateralized pledged assets	(173)	(7)
Change in collateralized pledged liabilities	2,890	569
Shareholder dividend paid	(4)	0
Purchase (redemption) of noncontrolling interests of consolidated company-sponsored investment funds	5	1
Net cash provided by (used in) financing activities	1,061	1,230
Change in cash and cash equivalents	483	959
Cash and cash equivalents, beginning of period	2,833	797
Cash and cash equivalents, end of period	3,316	1,756
Non-cash transactions from investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations	$ 1	$ 0